Trade Group Study: Hundreds of Rare Disease Drugs in Development

According to a new trade group report, the drug development pipeline is innovative and robust, with a high percentage of potential first-in-class medicines targeting targeting diseases with limited treatment options, including a number of rare diseases. http://www.highlighthealth.com/resources/trade-group-study-hundreds-of-rare-disease-drugs-in-development/

Advertisements
%d bloggers like this: